Thrimawithana TR - Search Results

1

Critical appraisal of commercially available suspending vehicles for extemporaneous compounding of cardiovascular medicines: physical and chemical stability mini review.

Thrimawithana TR, D'Amore S, Dib Y, Fadavi Firooz N, Fakhouri W, Saeed A, Allahham A. Thrimawithana TR, et al. Pharm Dev Technol. 2019 Jun;24(5):529-538. doi: 10.1080/10837450.2018.1526955. Epub 2018 Dec 20. Pharm Dev Technol. 2019. PMID: 30238838 Review.

2

Natural antioxidants in the management of Parkinson's disease: Review of evidence from cell line and animal models.

Abdul-Latif R, Stupans I, Allahham A, Adhikari B, Thrimawithana T. Abdul-Latif R, et al. J Integr Med. 2021 Jul;19(4):300-310. doi: 10.1016/j.joim.2021.03.007. Epub 2021 Mar 27. J Integr Med. 2021. PMID: 33863692 Review.

3

Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants.

Abdelkader H, Fathalla Z, Seyfoddin A, Farahani M, Thrimawithana T, Allahham A, Alani AWG, Al-Kinani AA, Alany RG. Abdelkader H, et al. Adv Drug Deliv Rev. 2021 Oct;177:113957. doi: 10.1016/j.addr.2021.113957. Epub 2021 Sep 1. Adv Drug Deliv Rev. 2021. PMID: 34481032 Review.

4

Educational Interventions in Immigrants for Asthma and COPD: A Systematic Review.

Al-Juhaishi M, Lim CX, Chan V, Stupans I, Thrimawithana TR. Al-Juhaishi M, et al. Among authors: thrimawithana tr. Patient Prefer Adherence. 2023 Dec 11;17:3245-3257. doi: 10.2147/PPA.S431224. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 38106364 Free PMC article. Review.

5

The suprachoroidal pathway: a new drug delivery route to the back of the eye.

Rai Udo J, Young SA, Thrimawithana TR, Abdelkader H, Alani AW, Pierscionek B, Alany RG. Rai Udo J, et al. Among authors: thrimawithana tr. Drug Discov Today. 2015 Apr;20(4):491-5. doi: 10.1016/j.drudis.2014.10.010. Epub 2014 Oct 30. Drug Discov Today. 2015. PMID: 25448755 Review.

6

Drug delivery to the lens for the management of cataracts.

Thrimawithana TR, Rupenthal ID, Räsch SS, Lim JC, Morton JD, Bunt CR. Thrimawithana TR, et al. Adv Drug Deliv Rev. 2018 Feb 15;126:185-194. doi: 10.1016/j.addr.2018.03.009. Epub 2018 Mar 28. Adv Drug Deliv Rev. 2018. PMID: 29604375 Review.

7

Preface.

Bunt C, Urtti A, Thrimawithana T. Bunt C, et al. Adv Drug Deliv Rev. 2018 Feb 15;126:1-2. doi: 10.1016/j.addr.2018.05.003. Adv Drug Deliv Rev. 2018. PMID: 29887021 No abstract available.

8

Effect of cations on the microstructure and in-vitro drug release of κ- and ι-carrageenan liquid and semi-solid aqueous dispersions.

Thrimawithana TR, Young S, Alany RG. Thrimawithana TR, et al. J Pharm Pharmacol. 2011 Jan;63(1):11-8. doi: 10.1111/j.2042-7158.2010.01171.x. Epub 2010 Nov 16. J Pharm Pharmacol. 2011. PMID: 21155810

9

Drug delivery to the posterior segment of the eye.

Thrimawithana TR, Young S, Bunt CR, Green C, Alany RG. Thrimawithana TR, et al. Drug Discov Today. 2011 Mar;16(5-6):270-7. doi: 10.1016/j.drudis.2010.12.004. Epub 2010 Dec 15. Drug Discov Today. 2011. PMID: 21167306 Review.

10

In-vitro and in-vivo evaluation of carrageenan/methylcellulose polymeric systems for transscleral delivery of macromolecules.

Thrimawithana TR, Young SA, Bunt CR, Green CR, Alany RG. Thrimawithana TR, et al. Eur J Pharm Sci. 2011 Oct 9;44(3):399-409. doi: 10.1016/j.ejps.2011.08.026. Epub 2011 Sep 1. Eur J Pharm Sci. 2011. PMID: 21907798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page